AAAAAA

   
Results: 1-3 |
Results: 3
ADENOVIRUS-MEDIATED EX-VIVO IMMUNOGENE AND IN-VIVO COMBINATION GENE-THERAPY STRATEGIES INDUCE A SYSTEMIC ANTITUMOR IMMUNE DEFENSE IN THE MOUSE B16 MELANOMA MODEL
Authors: BONNEKOH B GREENHALGH DA CHEN SH BICKENBACH J BLOCK A RICH SS KRIEG T WOO SLC ROOP DR
Citation: B. Bonnekoh et al., ADENOVIRUS-MEDIATED EX-VIVO IMMUNOGENE AND IN-VIVO COMBINATION GENE-THERAPY STRATEGIES INDUCE A SYSTEMIC ANTITUMOR IMMUNE DEFENSE IN THE MOUSE B16 MELANOMA MODEL, Cancer gene therapy, 4(5), 1997, pp. 305-305
CHARACTERIZATION OF THE MOUSE LORICRIN GENE
Authors: DISEPIO D BICKENBACH J LONGLEY MA BUNDMAN DS ROTHNAGEL JA ROOP DR
Citation: D. Disepio et al., CHARACTERIZATION OF THE MOUSE LORICRIN GENE, Journal of investigative dermatology, 102(4), 1994, pp. 546-546
TARGETED EXPRESSION OF A DOMINANT-NEGATIVE RETINOIC ACID RECEPTOR MUTANT IN THE EPIDERMIS OF TRANSGENIC MICE RESULTS IN LOSS OF BARRIER FUNCTION AND NEONATAL LETHALITY
Authors: IMAKADO S BICKENBACH J ROTHNAGEL JA BUNDMAN D WALCZAK VR WISNIEWSKI S GORDON JS HEYMAN R ROOP DR
Citation: S. Imakado et al., TARGETED EXPRESSION OF A DOMINANT-NEGATIVE RETINOIC ACID RECEPTOR MUTANT IN THE EPIDERMIS OF TRANSGENIC MICE RESULTS IN LOSS OF BARRIER FUNCTION AND NEONATAL LETHALITY, Journal of investigative dermatology, 102(4), 1994, pp. 547-547
Risultati: 1-3 |